Search Results - "Rabascio, C"
-
1
A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis
Published in Transfusion and apheresis science (01-10-2020)“…Upfront single or tandem ASCT still represents an integral part of treatment for patients with multiple myeloma. The combination of intermediate dose (ID) -…”
Get full text
Journal Article -
2
Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine as Therapy in Untreated and Relapsed Waldenström's Macroglobulinemia
Published in Clinical lymphoma, myeloma and leukemia (01-02-2011)“…Abstract With the aim to assess the efficacy of subcutaneous cladribine in combination with rituximab, 29 newly diagnosed/pretreated WM patients were enrolled…”
Get full text
Journal Article -
3
-
4
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2′-deoxyadenosine (2-CdA) and Rituximab
Published in Leukemia research (01-04-2010)“…Abstract Purpose Resistance to nucleoside analogues agents is likely to be multifactorial and could involve a number of mechanisms affecting drug penetration,…”
Get full text
Journal Article -
5
A new comprehensive gene expression panel to study tumor micrometastasis in patients with high-risk breast cancer
Published in International journal of oncology (01-04-2007)“…The incidence and prognostic relevance of bone marrow (BM) and leukapheresis (PBPC) tumor cell contamination (TCC) in breast cancer patients is still to be…”
Get full text
Journal Article -
6
Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma
Published in Leukemia (01-08-2000)“…Recent reports suggest that green tea consumption may prevent or delay the growth of human cancer, possibly by impairing tumor invasion and/or by an…”
Get full text
Journal Article -
7
Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin's lymphoma: A clinical and biological analysis
Published in Leukemia & lymphoma (01-02-2007)Get full text
Journal Article -
8
Is there a role for 'modified VAD' in the treatment of multiple myeloma?
Published in Ecancermedicalscience (01-01-2009)“…VAD, (Vincristine, Doxorubicin and Dexamethasone) was initially proposed as a salvage therapy for myeloma patients in whom prior alkylating agent therapy…”
Get full text
Journal Article -
9
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma
Published in Cancer research (Chicago, Ill.) (01-06-2002)“…The chemokine stromal cell-derived factor-1 (CXCL12/SDF-1) and its monogamous receptor CXCR4 are involved in trafficking of B cells and hematopoietic…”
Get full text
Journal Article -
10
Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease
Published in International immunology (01-09-2012)“…Human cytomegalovirus (hCMV) infection and its reactivation correlate both with the increased risk and with the worsening of graft-versus-host disease (GVHD)…”
Get full text
Journal Article -
11
Assessing tumor angiogenesis: Increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells
Published in Cancer research (Chicago, Ill.) (15-06-2004)“…No markers are currently available to indicate the angiogenic profile of a specific malignant disease nor to predict response to antiangiogenic therapies…”
Get full text
Journal Article -
12
IgG antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease
Published in Bone marrow transplantation (Basingstoke) (01-03-2009)“…Chronic Graft versus Host Disease (GVHD) with skin involvement similar to that of patients with systemic sclerosis (SSc) can be observed in allogeneic stem…”
Get full text
Journal Article -
13
Successfull autologous peripheral blood stem cells collection by a single dose of pegfilgrastim in combination with chemotherapy in patients with malignant lymphomas
Published in Bone marrow transplantation (Basingstoke) (01-03-2009)“…Granulocyte colony-stimulating factors (G-CSF) alone or in combination with CHT are standard procedures for mobilization of peripheral blood stem cells (PBSC)…”
Get full text
Journal Article -
14
Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model : Frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production
Published in Cancer research (Chicago, Ill.) (01-05-2000)“…Recent studies have suggested that non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice transplanted with human hematological malignancies show…”
Get full text
Journal Article -
15
hCNT1 in Waldenström’s macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) patients (pts): A possible predictive biomarker of 2-chloro-2`-deoxyadenosine (2-CDA) clinical activity
Published in Journal of clinical oncology (20-06-2006)“…Abstract only 13087 Background: The resistance mechanism to 2-CDA is not completely known. In this study we used pharmacogenomic to identify genetic factors…”
Get full text
Journal Article -
16
LAB-ANGIOGENESIS AND INVASION
Published in Neuro-oncology (Charlottesville, Va.) (01-10-2012)Get full text
Journal Article -
17
Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer
Published in Clinical cancer research (15-09-2004)“…Purpose: The purpose of this study was to investigate the incidence and prognostic relevance of tumor cell detection in granulocyte colony-stimulating…”
Get full text
Journal Article -
18
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer
Published in Journal of clinical oncology (15-07-2004)“…Abstract only…”
Get full text
Journal Article -
19
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer
Published in Journal of clinical oncology (15-07-2004)“…Abstract only…”
Get full text
Journal Article -
20
In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue
Published in Experimental hematology (01-08-2002)“…We studied the in vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue collected from adults with head and neck cancer…”
Get full text
Journal Article